Works matching AU Zalcberg, John

Results: 134
    1
    2

    Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials.

    Published in:
    JNCI Cancer Spectrum, 2022, v. 6, n. 2, p. 1, doi. 10.1093/jncics/pkac014
    By:
    • McCleary, Nadine J;
    • Harmsen, William S;
    • Haakenstad, Ellana;
    • Cleary, James M;
    • Meyerhardt, Jeffrey A;
    • Zalcberg, John;
    • Adams, Richard;
    • Grothey, Axel;
    • Sobrero, Alberto F;
    • Cutsem, Eric Van;
    • Goldberg, Richard M;
    • Peeters, Marc;
    • Tabernero, Josep;
    • Seymour, Matt;
    • Saltz, Leonard B;
    • Giantonio, Bruce J;
    • Arnold, Dirk;
    • Rothenberg, Mace L;
    • Koopman, Miriam;
    • Schmoll, Hans-Joachim
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    CD8<sup>+</sup> tumor‐infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival.

    Published in:
    Clinical & Translational Immunology, 2020, v. 9, n. 7, p. 1, doi. 10.1002/cti2.1155
    By:
    • Millen, Rosemary;
    • Hendry, Shona;
    • Narasimhan, Vignesh;
    • Abbott, Rebecca;
    • Croxford, Matthew;
    • Gibbs, Peter;
    • Tie, Jeanne;
    • Wong, Hui‐Li;
    • Jones, Ian;
    • Kosmider, Suzanne;
    • Byrne, David;
    • Zalcberg, John;
    • Fox, Stephen;
    • Desai, Jayesh;
    • Visvanathan, Kumar;
    • Ramsay, Robert G;
    • Tran, Ben
    Publication type:
    Article
    9
    10
    11
    12
    13

    The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours.

    Published in:
    Targeted Oncology, 2022, v. 17, n. 2, p. 95, doi. 10.1007/s11523-022-00869-y
    By:
    • Foo, Tiffany;
    • Goldstein, David;
    • Segelov, Eva;
    • Shapiro, Jeremy;
    • Pavlakis, Nick;
    • Desai, Jayesh;
    • Yip, Desmond;
    • Zalcberg, John;
    • Price, Timothy J.;
    • Nagrial, Adnan;
    • Chantrill, Lorraine;
    • Burge, Matt;
    • Karapetis, Christos S.;
    • Tebbutt, Niall;
    • Roy, Amitesh C.
    Publication type:
    Article
    14

    TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/ TROG/EORTC/NCIC CTG).

    Published in:
    BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1529-x
    By:
    • Leong, Trevor;
    • Smithers, B. Mark;
    • Michael, Michael;
    • Gebski, Val;
    • Boussioutas, Alex;
    • Miller, Danielle;
    • Simes, John;
    • Zalcberg, John;
    • Haustermans, Karin;
    • Lordick, Florian;
    • Schuhmacher, Christoph;
    • Swallow, Carol;
    • Darling, Gail;
    • Wong, Rebecca
    Publication type:
    Article
    15

    TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/ TROG/EORTC/NCIC CTG)

    Published in:
    BMC Cancer, 2015, v. 15, n. 1, p. 532, doi. 10.1186/s12885-015-1529-x
    By:
    • Leong, Trevor;
    • Smithers, B Mark;
    • Michael, Michael;
    • Gebski, Val;
    • Boussioutas, Alex;
    • Miller, Danielle;
    • Simes, John;
    • Zalcberg, John;
    • Haustermans, Karin;
    • Lordick, Florian;
    • Schuhmacher, Christoph;
    • Swallow, Carol;
    • Darling, Gail;
    • Wong, Rebecca
    Publication type:
    Article
    16

    TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).

    Published in:
    2015
    By:
    • Leong, Trevor;
    • Smithers, B Mark;
    • Michael, Michael;
    • Gebski, Val;
    • Boussioutas, Alex;
    • Miller, Danielle;
    • Simes, John;
    • Zalcberg, John;
    • Haustermans, Karin;
    • Lordick, Florian;
    • Schuhmacher, Christoph;
    • Swallow, Carol;
    • Darling, Gail;
    • Wong, Rebecca
    Publication type:
    journal article
    17
    18

    Population DNA screening for medically actionable disease risk in adults.

    Published in:
    Medical Journal of Australia, 2022, v. 216, n. 6, p. 278, doi. 10.5694/mja2.51454
    By:
    • Lacaze, Paul A;
    • Tiller, Jane;
    • Winship, Ingrid;
    • Lacaze, Paul;
    • Brotchie, Adam;
    • McNeil, John;
    • Zalcberg, John;
    • Thomas, David;
    • Milne, Roger;
    • James, Paul;
    • Delatycki, Martin;
    • Young, Mary‐Anne;
    • Nowak, Kristen;
    • Nguyen‐Dumont, Tu;
    • Southey, Melissa;
    • Ademi, Zanfina;
    • Bruinsma, Fiona;
    • Riaz, Moeen;
    • Terrill, Bronwyn;
    • Kirk, Judy
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Victorian Lung Cancer Service Redesign Project: impacts of a quality improvement collaborative on timeliness and management in lung cancer.

    Published in:
    Internal Medicine Journal, 2021, v. 51, n. 12, p. 2061, doi. 10.1111/imj.15043
    By:
    • Largey, Geraldine;
    • Briggs, Peter;
    • Davies, Heather;
    • Underhill, Craig;
    • Ross, Cara;
    • Harvey, Kellie;
    • Blum, Robert;
    • Parker, Carol;
    • Guthrie, Christal;
    • Parente, Phillip;
    • Trevorah, Brooke;
    • Torres, Javier;
    • Mott, Carole;
    • Lancaster, Cheryl;
    • Brand, Margaret;
    • Earnest, Arul;
    • Pellegrini, Breanna;
    • Reed, Marita;
    • Zalcberg, John;
    • Stirling, Rob
    Publication type:
    Article
    31
    32
    33
    34

    What matters for people with brain cancer? Selecting clinical quality indicators for an Australian Brain Cancer Registry.

    Published in:
    Neuro-Oncology Practice, 2022, v. 9, n. 1, p. 68, doi. 10.1093/nop/npab055
    By:
    • Matsuyama, Misa;
    • Sachchithananthan, Mythily;
    • Leonard, Robyn;
    • Besser, Michael;
    • Nowak, Anna K;
    • Truran, Donna;
    • Vajdic, Claire M;
    • Zalcberg, John R;
    • Gan, Hui K;
    • Gedye, Craig;
    • Varikatt, Winny;
    • Koh, Eng-Siew;
    • Kichenadasse, Ganessan;
    • Sim, Hao-Wen;
    • Gottardo, Nicholas G;
    • Spyridopoulos, Desma;
    • Jeffree, Rosalind L
    Publication type:
    Article
    35
    36
    37

    Quality of life in patients with K- RAS wild-type colorectal cancer.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 2, p. 181, doi. 10.1002/cncr.28410
    By:
    • Ringash, Jolie;
    • Au, Heather‐Jane;
    • Siu, Lillian L.;
    • Shapiro, Jeremy D.;
    • Jonker, Derek J.;
    • Zalcberg, John R.;
    • Moore, Malcolm J.;
    • Strickland, Andrew;
    • Kotb, Rami;
    • Jeffery, Mark;
    • Alcindor, Thierry;
    • Ng, Siobhan;
    • Salim, Muhammad;
    • Sabesan, Sabe;
    • Easaw, Jay C.;
    • Shannon, Jenny;
    • El‐Tahche, Fabyolla;
    • Walters, Ian;
    • Tu, Dongsheng;
    • O'Callaghan, Christopher J.
    Publication type:
    Article
    38
    39

    BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database.

    Published in:
    2021
    By:
    • Cohen, Romain;
    • Liu, Heshan;
    • Fiskum, Jack;
    • Adams, Richard;
    • Chibaudel, Benoist;
    • Maughan, Timothy S;
    • Cutsem, Eric Van;
    • Venook, Alan;
    • Douillard, Jean-Yves;
    • Heinemann, Volker;
    • Punt, Cornelis Ja;
    • Falcone, Alfredo;
    • Bokemeyer, Carsten;
    • Kaplan, Richard;
    • Lenz, Heinz-Josef;
    • Koopman, Miriam;
    • Yoshino, Takayuki;
    • Zalcberg, John;
    • Grothey, Alex;
    • Gramont, Aimery de
    Publication type:
    journal article
    40
    41
    42
    43
    44
    45

    Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial.

    Published in:
    BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10379-9
    By:
    • Schöffski, Patrick;
    • George, Suzanne;
    • Heinrich, Michael C.;
    • Zalcberg, John R.;
    • Bauer, Sebastian;
    • Gelderblom, Hans;
    • Serrano, César;
    • Jones, Robin L.;
    • Attia, Steven;
    • D'Amato, Gina;
    • Chi, Ping;
    • Reichardt, Peter;
    • Becker, Claus;
    • Shi, Kelvin;
    • Meade, Julie;
    • Ruiz-Soto, Rodrigo;
    • Blay, Jean-Yves;
    • von Mehren, Margaret
    Publication type:
    Article
    46
    47

    Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 17, p. 1182, doi. 10.1093/jnci/djp232
    By:
    • Mittmann, Nicole;
    • Au, Heather-Jane;
    • Tu, Dongsheng;
    • O'Callaghan, Christopher J.;
    • Isogai, Pierre K.;
    • Karapetis, Christos S.;
    • Zalcberg, John R.;
    • Evans, William K.;
    • Moore, Malcolm J.;
    • Siddiqui, Jehan;
    • Findlay, Brian;
    • Colwell, Bruce;
    • Simes, John;
    • Gibbs, Peter;
    • Links, Matthew;
    • Tebbutt, Niall C.;
    • Jonker, Derek J.
    Publication type:
    Article
    48

    Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis.

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211020547
    By:
    • Yin, Jun;
    • Dawood, Shaheenah;
    • Cohen, Romain;
    • Meyers, Jeff;
    • Zalcberg, John;
    • Yoshino, Takayuki;
    • Seymour, Matthew;
    • Maughan, Tim;
    • Saltz, Leonard;
    • Van Cutsem, Eric;
    • Venook, Alan;
    • Schmoll, Hans-Joachim;
    • Goldberg, Richard;
    • Hoff, Paulo;
    • Hecht, J. Randolph;
    • Hurwitz, Herbert;
    • Punt, Cornelis;
    • Diaz Rubio, Eduard;
    • Koopman, Miriam;
    • Cremolini, Chiara
    Publication type:
    Article
    49
    50